Abstract
Pharmaceutical administration in Japan is governed primarily by the Pharmaceutical Affairs Law (PAL; Law No. 145 issued in 1960) that controls clinical research, manufacturing, marketing, labeling, and safety of drugs, diagnostics, and medical devices (from here on referred to collectively as drugs). The need for a clinical trial notification (CTN) submission to the governing agency before human use of a new drug, for manufacturing/distribution approval application (MAA) before manufacturing/marketing of a new drug product, and for reliability/compliance review on application of a dossier is defined in Articles 80 (2) and 14, respectively, of the PAL. Procedures for implementing the PAL rules are the Enforcement Regulations of PAL (ER-PAL, Ministerial Ordinance No. 1 issued in 1961). Table 1 presents the ER-PAL articles and the laws they describe.
Chapter PDF
References
Organization of the MHLW; http://www.mhlw.go.jp/english/org/detail/index.html (Accessed 11 March 2008).
Organization of the PMDA; http://www.pmda.go.jp/english/about/organization.html (Accessed 11 March 2008).
ICH E3, Guideline for Industry, Structure and Content of Clinical Study Reports, July 1996.
Notification No. 0928010 of the Evaluation and Licensing Division, PMSB dated September 28, 2007. http://www.pmda.go.jp/topics/h200110kohyo.html (Accessed 11 March 2008).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Birkhäuser Verlag Basel/Switzerland
About this chapter
Cite this chapter
Ishida, T., Kurusu, K. (2009). Clinical trial procedures and approval processes in Japan. In: Wood, L.F., Foote, M. (eds) Targeted Regulatory Writing Techniques: Clinical Documents for Drugs and Biologics. Birkhäuser, Basel. https://doi.org/10.1007/978-3-7643-8362-6_12
Download citation
DOI: https://doi.org/10.1007/978-3-7643-8362-6_12
Published:
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-7643-8361-9
Online ISBN: 978-3-7643-8362-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)